February 24, 2011 – A percutaneous microwave tissue ablation (pMTA) system will be unveiled at the European Congress of Radiology (ECR) in Vienna, Austria, March 4-7. The Accu2i pMTA system, from Microsulis Medical is cleared for use in Europe, the United States and Canada.
Alongside the Accu2i, Microsulis will feature case studies from key centers using the system.
It is the most powerful tissue ablation system currently available. It combines extreme ease of use with the widest range of clinical applications for rapid, precise coagulation of unwanted tissue masses, while avoiding the risks associated with longer, more invasive surgical interventions. The device is a single high power high frequency 2.45 GHz closed, water-cooled microwave needle that is 1.8 mm in diameter. It can address tissue masses more than 5 cm in size in just six minutes, making it between three and 10 times faster than other systems. Clinicians have used the device primarily in the treatment of liver and lung disease.
For more information: visit www.acculis.com
October 30, 2026 
